Effect of walnut-enriched restructured meat in the antioxidant status of overweight/obese senior subjects with at least one extra chd-risk factor

Journal of the American College of Nutrition

Volumn 26, Issue 3, 2007, Pages 225-232

  Canales, Amaia ^a,b   Benedí, Juana ^a,b   Nus, Meritxell ^a,b   Librelotto, Josana ^a,b   Sánchez Montero, Jose M ^a,b   Sánchez Muniz, Francisco J ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antioxidant status; Functional food; Lipid peroxidation; Walnut enriched meat

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; SUPEROXIDE DISMUTASE; URIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENERGY; ENZYME ACTIVITY; ENZYME SUBSTRATE; ERYTHROCYTE; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MALE; OBESITY; OXIDATIVE STRESS; RISK FACTOR; SMOKING; URIC ACID BLOOD LEVEL; WALNUT;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CARDIOVASCULAR DISEASES; CATALASE; CROSS-OVER STUDIES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; JUGLANS; LIPIDS; MALE; MEAT PRODUCTS; MIDDLE AGED; OBESITY; OVERWEIGHT; OXIDATION-REDUCTION; OXIDATIVE STRESS; RISK FACTORS; SEX FACTORS; SUPEROXIDE DISMUTASE;

JUGLANS;

EID: 34547297149     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2007.10719605     Document Type: Article

References (56)

1. Iwamoto M, Imaizumi K, Sato M, Hirooka Y, Sakai K, Takeshita A, Kono M: Serum lipid profiles in Japanese women and men during consumption of walnuts. Eur J Clin Nutr 56:629–637, 2002.
2. Feldman EB: The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 132: 1062–1101, 2002.
3. Ros E, Nunez I, Pérez-Heras A, Serra M, Gilabert R, Casals E, Deulofeu R: A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 109:1609–1614, 2004.
4. Sabate J: Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr 70:500–503, 1999.
5. U.S. Food and Drug Administration: Labelling and Dietary Supplements. Qualified Health Claims: Letter of Enforcement Discretion. Walnuts and Coronary Heart Disease. Version current 9 March 2004. Internet: http://www.cfsan.fda.gov/_dms/qhcnuts3.html (accessed 28 October 2004).
6. Nus M, Ruperto M, Sa´nchez-Muniz FJ: Nuts, cardio and cerebrovascular risks. A Spanish perspective. Arch Latinoam Nutr 54: 137–148, 2004.
7. Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD: Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 70:504S–11S, 1999.
8. Ministerio de Agricultura Pesca y Alimentación (MAPA): Internet: http://www.mapya.es/es/alimentacion/pags/consumo/consumo.htm (accessed 22 November 2005).
9. Aranceta Batrina A: Situación actual de la alimentación en Espan˜a. In “Guía Alimentaria para la población Espan˜ola Sociedad Espan ˜ola Nutrición Comunitaria.” Madrid: Editorial IM&C, S.A., pp 195–205, 2001.
10. Fidanza F: Tree nuts in the Mediterranean diet context. II Conferencia sobre Salud y Frutos Secos-Fundación Nucis. Barcelona 2002. Internet: http://www.nucis.org/pdf/nuts_fidanza_cmc.pdf.
11. Olmedilla-Alonso B, Granado-Lorenzio F, Herrero-Barbudo C, Blanco-Navarro I: Nutritional approach for designing meat-based functional food products with nuts. Crit Rev Food Sci Nutr 46: 537–542, 2006.
12. Weinbrenner T, Cladellas M, Covas MI, Fito M, Tomas M, Senti M, Bruguera J, Marrugat J: High oxidative stress in patients with stable coronary heart disease. Atherosclerosis 168:99–106, 2003.
13. Johansen JS, Harris AK, Rychly D, Ergul A: Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovascular Diabetology 4:1–11, 2005.
14. Sies H: “Oxidative Stress: Oxidants and Antioxidants”. San Diego: Academic Press, 1991.
15. Esterbauer H, Gebicki J, Puhl H, Jürgens G: The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radical Biol Med 13:341–390, 1992.
16. Canales A, Sánchez-Muniz FJ: Paraoxonase, something more than an enzyme? Med Clin (Barc) 121:537–548, 2003.
17. Tapsell LC, Gillen LJ, Patch CS, Batterham M, Owen A, Baré M Kennedy M: Including walnuts in a low-fat/modified diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27:2777–2783, 2004.
18. Reilly M, Practico D, Delanty N, DiMinno G, Tremoli E, Rader D, Kapoor S, Rokach J, Lawson J, FitzGerald GA: Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation 98:2822–2828, 1998.
19. Serrano A, Cofrades S, Ruiz-Capillas C, Olmedilla-Alonso B, Herrero-Barbudo C, Jiménez-Colmenero F: Nutritional profile of restructured beef steak with added walnuts. Meat Sci 70:647–654, 2005.
20. National Cholesterol Education Programme. National Institutes of Health. National Heart, Lung and Blood Institute: ATP Guidelines at a glance: Quick desk reference. Version current May 2001. Internet: http://www.nhlbi.nih.gov/guidelines/cholesterol (accessed 28 October 2005).
21. Moreiras O, Carbajal A, Cabrera L (eds): “Tablas de Composición de Alimentos.” Madrid: Editorial Pirámide, 2001.
22. Olmedilla Alonso B, Granado Lorencio F, Herrero Barbudo C, Blanco Navarro I, Sánchez-Muniz FJ (in the name of subproject 3 researchers): Productos cárnicos funcionales preparados con nuez. Evaluación del efecto funcional. Parte 3. CTC Alimentación 24: 37–41, 2005.
23. Fairbanks VF, Klee GG: Biochemical aspects of hematology. In Burtis CA, Ashwood ER (eds): “Tietz Textbook of Clinical Chemistry,” 3rd ed. Philadelphia: WB Saunders, pp 1642–1710, 1998.
24. Trinder P: Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6:24–27, 1969.
25. Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474, 1974.
26. Aebi M: Catalase in vitro. Method Enzymol 105:121–126, 1984.
27. Hissin PJ, Hilf R: A fluorimetric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214–226, 1976.
28. Tomas M, Senti M, Garcia-Faria F, Garcia-Faria F, Vila J, Torrents A, Covas M, Marrugat J: Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 20:2113–2119, 2000.
29. Diplock AT, Aggett PJ, Ashwell M, Bornet F, Fern EB, Roberfroid MB: Scientific concepts of functional food in Europe: Consensus document. Br J Nutr 81:1–27, 1999.
30. Edwards K, Kwaw I, Mataud J, Kurtz I: Effect of pistachio nuts on serum lipid levels in patients with moderate hypercholesterolemia. J Am Coll Nutr 18:229–232, 1999.
31. Morgan JM, Horton K, Rees D, Carey C, Walker K, Capuzzi DM: Effects of walnut consumption as part of a low-fat, low-cholesterol diet on serum cardiovascular risk factors. Int J Vitam Nutr Res 72:341–347, 2002.
32. Almario RU, Vonghavaravat V, Wong R, Kasim-Karakas SE: Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr 74:72–79, 2001.
33. Garcia-Lorda P, Megias-Rangil I, Salas-Salvadó J: Nut consumption, body weight and insulin resistance. Eur J Clin Nutr 57:8–11, 2003.
34. U.S. Department of Agriculture, Agricultural Research Service: USDA National Nutrient Database for Standard Reference, Release 18. Nutrient Data Laboratory Home Page, 2005, http://www.ars.usda.gov/ba/bhnrc/ndl
35. Olmedilla B, Sánchez-Muniz FJ, Jiménez Colmenero F (en representación de los investigadores del Proyecto AGL-2001-2398-C03): Cárnicos funcionales y riesgo cardiovascular. Revista de Nutrición Práctica 10:34–6, 2006.
36. Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K, Horkko S, Palinski W, Quehenberger O, Shaw P, Steinberg D, Terpstra V, Witztum JL: Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci 947:214–222, 2001.
37. Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM: Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 131:2837–2842, 2001.
38. Fukuda T, Ito H, Yoshida T: Antioxiadtive polyphenols from walnuts (Juglans regia L). Phytochemistry 63:795–801, 2003.
39. Li D, Saldeen T, Romero F, Mentha JL: Relative effects of alpha and gamma-tocopherol and low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J Cardiovasc Pharmacol Ther 4:219–226, 1999.
40. Lemaitre D, Varicel E, Polette A, Lagarde M: Effects of fatty acids on human platelet glutathione peroxidase: possible role of oxidative stress. Biochem Pharmacol 53:479–486, 1997.
41. Davies H, Richter RJ, Kiefer M, Broomfield C, Sowalla J, Furlong CE: The human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14:334–336, 1996 42.
42. Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M: Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid arteriosclerotic lesions. Circulation 101: 2510–2517, 2000.
43. Sutherland WH, Walker RJ, de Jong SA, van Rij AM, Phillips V, Walker HL: Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler Thromb Vasc Biol 19:1340–1347, 1999.
44. Mackness M, Boullier A, Hennuyer N, Hennuyer N, Mackness B, Hall M, Tailleux A, Duriez P, Delfly B, Durrington P, Fruchart JC, Duverger N, Caillaud JM, Castro G: Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits. Biochem Biophys Res Commun 269:232–236, 2000.
45. Kudchodkar BJ, Lacko AG, Dory L, Fungwe TV: Dietary fat modulates serum paraoxonase 1 activity in rats. J Nutr 130:2427–2433, 2000.
46. Turay J, Grniakova V, Valka J: Changes in paraoxonase and apolipoprotein A-I, B, C-III and E in subjects with combined familiar hyperlipoproteinemia treated with ciprofibrate. Drugs Exp Clin Res 26:83–88, 2000.
47. Kleemola P, Freese R, Jauhiainen M, Pahlman R, Alfthan G, Mutanen M: Dietary determinants of serum paraoxonase activity in healthy humans. Atherosclerosis 160:425–432, 2000.
48. Simon E, Paul JL, Atger V, Simon A, Moatti N: Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men. Atherosclerosis 138:375–381, 1998.
49. Yalcin AS, Sabuncu N, Kilinc A, Gulcan G, Emerk K: Increased plasma and erythrocyte lipid peroxidation in hyperlipidemic individuals. Atherosclerosis 80:168–170, 1989.
50. Nichole L, Flintoff-Dye F, Omaye ST: Antioxidant effects of conjugated linoleic acid isomers in isolated human low density lipoproteins. Nutr Res 25:1–12, 2005.
51. Menone ML, Pflugmache S: Effects of 3-chlorobyfphenyl on photosynthetic oxygen production glutathione content in the detoxication enzymes in the acuatic macrocytes. Ceratophyllum demersum. Chemosphere 60:79–84, 2005.
52. Düken H, Kelle M, Tumer C, Denüz D, Baylan Y, Sermet A: Effects of cigarette smoking on blood antioxidant status in shortterm and long-term smokers. Turk J Med Sci 31:553–537, 2001.
53. Solak ZA, Kabaroglu C, Cok G, Parildar Z, Bayindir U, Ozmen D, Bayindir O: Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people. Clin Exp Med 5:99–105, 2005.
54. Smith DR, Wood R, Tseng S, Smith SM: Increased beef consumption increases apolipoprotein A-I but not serum cholesterol of mildly hypercholesterolemic men with different levels of habitual beef intake. Exp Boil Med 227:266–275, 2002.
55. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42:474–480, 2003.
56. Haque R, Bin-Hafeez B, Parvez S, Pandey S, Sayeed I, Ali M, Raisuddin S: Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 22:473–480, 2003.